Pricing And Packaging

Start with the operating model

flowchart LR
    Foundation["Structured platform foundation"] --> Scope["Scope of use"]
    Scope --> Governance["Governance depth"]
    Governance --> Support["Implementation and support model"]

TrialStack pricing is built around operational depth, governance depth, and implementation burden, not around selling standards, generic AI, or disconnected feature bundles.

Every plan starts from the same core product architecture:

• structured trial records and connected context
• standards-aware protocol structure
• AI-assisted drafting inside governed product workflows
• visible history and supported export surfaces where the product already supports them

The step-up is how much controlled study-startup work the team needs to run through that foundation.

Commercial snapshot

• every tier includes a 7-day free trial
• teams can pay monthly or annually
• annual billing saves about 17%
• the public buying posture is cancel anytime, no setup fee, and no migration required
• monthly token capacity scales by plan: 500K, 2M, and 8M included
• support and security posture step up with the package, not just raw volume

The three packaging questions

Ask three questions when choosing a plan:

1. Is this one active study or a broader portfolio?
2. Is the team using TrialStack as a focused drafting workspace or as the governed operating surface for study-definition work?
3. Does the rollout need starter setup, governed workflow design, or broader organizational implementation and support?

Plan intent

Plan	Best fit	Why it exists
Ignite	Academic teams, early biotech groups, and focused study teams	Gives one study team a structured place to draft and coordinate without pretending it already needs the full governed operating model
Accelerate	Serious study teams, CTUs, academic CROs, and sponsors running one study or a small portfolio	Makes governed study-definition work, controlled review, reusable workflows, and downstream readiness the default way the team operates
Scale	Multi-study sponsors, CROs, CTU programs, and broader enterprise delivery groups	Adds program governance, organizational controls, implementation depth, and SLA-backed support accountability

Current package snapshot

Plan	Public price	Capacity	Support
Ignite	€500 / month	1 active trial, 3 users, 500K tokens / month	Email support
Accelerate	€2,500 / month	3 active trials, 8 users, 2M tokens / month	Email + business-hours phone
Scale	€10,000+ / month	10+ / custom active trials, Unlimited users, 8M included tokens / month	Email + priority phone

Limit snapshot

Area	Ignite	Accelerate	Scale
Evidence Packs	3 active, 3 templates	15 active, 10 templates	50 active, Unlimited templates
Documents	12 active, 8 templates	40 active, 25 templates	150 active, 50 templates
Insights	3 active	15 active	50 active
Revisions	10 active, 1 template	40 active, 5 templates	150 active, 15 templates
Connections	systems 8, contacts 25, interventions 10, organizations 10, personas 10, sites 5	systems 20, contacts 100, interventions 25, organizations 30, personas 30, sites 40	systems 40, contacts 500, interventions 100, organizations 100, personas 100, sites 200
Tools	configurable skills No, rules 5, concurrent runs 2	configurable skills Yes, rules 15, concurrent runs 5	configurable skills Yes, rules 50, concurrent runs 10
Security	SAML No, RBAC No, HIPAA BAA No, SCIM No, 2FA Yes	SAML No, RBAC Yes, HIPAA BAA Optional add-on, SCIM No, 2FA Yes	SAML Yes, RBAC Yes, HIPAA BAA Yes, SCIM Yes, 2FA Yes

What stays foundational across all plans

The following are part of the platform model and should not be treated as premium buzzwords:

• structured trial architecture
• standards-aware protocol structure
• connected study context
• AI-assisted drafting with human review
• versioned records and visible change history
• supported standards-based export surfaces where configured

What changes when teams move up

flowchart TD
    A["Ignite"] --> B["Accelerate"]
    B --> C["Scale"]
    A --> A1["Focused study workspace"]
    B --> B1["Governed study-definition operations"]
    C --> C1["Program governance and implementation depth"]

The real pricing fence is governance and operating depth:

• Ignite is for standards-aware structured authoring and AI-assisted document generation inside a focused study scope.
• Accelerate is where TrialStack becomes the governed study-definition and startup system for serious study work.
• Scale is for multi-study organizations that need broader control, organizational governance, and implementation/support accountability.

Capability fences that matter

The most important plan differences are not generic feature volume. They are operational consequences.

• Ignite: bounded capacity for one active trial, small-team collaboration, starter templates, and standard support
• Accelerate: more active capacity plus persona engagement feedback, feasibility review, configurable skills, RBAC, and stronger support expectations
• Scale: enterprise limits, identity controls such as SAML and SCIM, included HIPAA BAA support, and priority response expectations

Current tier fences

• Ignite: one active trial, three users, 500K monthly tokens, bounded limits across connected records, and email support
• Accelerate: everything in Ignite plus three active trials, eight users, 2M monthly tokens, persona engagement feedback, feasibility review, configurable skills, RBAC, and business-hours phone support
• Scale: everything in Accelerate plus 10+ or custom active trials, unlimited users, 8M included monthly tokens, SAML, SCIM, included HIPAA BAA, and priority response commitments

Standards framing

Use standards to explain product logic, not to decorate pricing.

• ICH M11 and CeSHarP are relevant when the conversation is about structured protocol organization and consistency.
• CDISC USDM is relevant when the conversation is about structured downstream representation and exchange readiness where supported.
• ICH Good Clinical Practice E6(R3) is relevant only when the conversation is about role clarity, review discipline, oversight, rationale capture, verification rigor, and governed change.

TrialStack can support more structured and controlled ways of working, but customer SOPs, validation, sign-off, and regulatory responsibilities remain with the customer.

Upgrade triggers

Move from Ignite to Accelerate when:

• more than one function must review and author in the same governed flow
• one trial and three users stop matching the team shape
• the team needs persona engagement feedback, feasibility review, configurable skills, or RBAC
• document, evidence, insight, revision, or connection limits are becoming the real blocker
• TrialStack becomes the study team’s operational source of truth

Move from Accelerate to Scale when:

• several studies must run under one governance model
• rollout requires enterprise identity controls such as SAML or SCIM
• HIPAA BAA must be included rather than treated as an optional add-on
• active capacity across templates, records, runs, or connected entities is outgrowing the mid-tier limits
• support expectations become SLA-backed and program-level rather than study-team level